Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits Zixi ZhangCancan WangQiming Liu Review Article Open access 03 April 2024 Pages: 329 - 342
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review Hiroaki HiraiwaTakahiro OkumuraToyoaki Murohara Review Article Open access 04 April 2024 Pages: 343 - 369
Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis Hon Jen WongNorman H. LinChing-Hui Sia Systematic Review 08 April 2024 Pages: 371 - 383
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis Hasan MushahidSyeda Ayesha ShahMuhammad Shariq Usman Systematic Review 29 April 2024 Pages: 385 - 398
Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry Rengin Çetin GüvençTolga Sinan GüvençMehmet Birhan Yılmaz Original Research Article 04 April 2024 Pages: 399 - 408
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany Alexander MichelCoralie LecomteThomas Evers Original Research Article 04 April 2024 Pages: 409 - 418
Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis Ishaque HameedSyeda Ayesha ShahMohammad Hamza Original Research Article 05 April 2024 Pages: 419 - 431
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020 Omar S. AlkheziLeo F. BuckleyJohn Fanikos Original Research Article 07 April 2024 Pages: 433 - 444
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China Penglei ChenYixiang WangXuwei Zheng Original Research Article 15 April 2024 Pages: 445 - 454
Comparative Genitourinary Safety of In-class Sodium-Glucose Cotransporter-2 Inhibitors among Patients with Heart Failure with Preserved Ejection Fraction: A Cohort Study Munaza RiazJingchuan GuoHaesuk Park Original Research Article 30 April 2024 Pages: 455 - 464
Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis” Hussain Sohail RangwalaHareer FatimaBurhanuddin Sohail Rangwala Letter to the Editor 02 April 2024 Pages: 465 - 466
Authors’ Reply to Rangwala et al: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis” Ioannis BellosSmaragdi MarinakiVassiliki Benetou Letter to the Editor 04 April 2024 Pages: 467 - 468